A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer.
about
microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathwayGenetic networks lead and follow tumor development: microRNA regulation of cell cycle and apoptosis in the p53 pathways.Urinary microRNA-10a and microRNA-30d serve as novel, sensitive and specific biomarkers for kidney injuryNovel small RNA expression libraries uncover hsa-miR-30b and hsa-miR-30c as important factors in anoikis resistance.RETRACTED: Role of microRNA 30a targeting insulin receptor substrate 2 in colorectal tumorigenesis.Integrative analyses of genetic variation, epigenetic regulation, and the transcriptome to elucidate the biology of platinum sensitivityRole of microRNA-30c targeting ADAM19 in colorectal cancer.Characterization of miRNomes in acute and chronic myeloid leukemia cell lines.MicroRNA-1908 functions as a glioblastoma oncogene by suppressing PTEN tumor suppressor pathwayHigh copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer.mir-30d Regulates multiple genes in the autophagy pathway and impairs autophagy process in human cancer cells.MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion.miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells.Mir-30d increases intracellular survival of Helicobacter pylori through inhibition of autophagy pathway.A serum microRNA signature as a prognostic factor for patients with advanced NSCLC and its association with tissue microRNA expression profilesCorrelations of microRNA-124a and microRNA-30d with clinicopathological features of breast cancer patients with type 2 diabetes mellitus.Amplification and up-regulation of MIR30D was associated with disease progression of cervical squamous cell carcinomas.MicroRNAs in the p53 network: micromanagement of tumour suppression.Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.The p53/microRNA connection in gastrointestinal cancer.Goserelin and bicalutamide treatments alter the expression of microRNAs in the prostate.miRNAs in urine: a mirror image of kidney disease?Downregulation of sorting nexin 10 is associated with overexpression of miR-30d during liver cancer progression in rats.Noncoding RNAs Regulating p53 and c-Myc Signaling.The Diagnostic and Prognostic Potential of microRNAs in Epithelial Ovarian Carcinoma.Identification of miR-30d as a novel prognostic maker of prostate cancer.Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells.miR-30d is related to asbestos exposure and inhibits migration and invasion in NCI-H2452 cellsDown-regulation of RE-1 silencing transcription factor (REST) in advanced prostate cancer by hypoxia-induced miR-106b~25.Confirmation of a metastasis-specific microRNA signature in primary colon cancer.MicroRNA-200 and microRNA-30 family as prognostic molecular signatures in ovarian cancer: A meta-analysis
P2860
Q33792672-3FAA2B92-7359-41D4-87DD-B8955863BA37Q34268565-93C496C9-277E-45B7-94EC-359F43EA4755Q34525152-1B8A617F-0982-4BFD-ACB4-8B3694510B1AQ35017844-5F5BE418-BF28-4C96-9B3C-BDE4D55388F0Q35097075-ABB472FC-6383-4137-8508-8982FEE724FCQ35150207-2CF02ED9-9FD1-40BD-B548-A023FA83E4F2Q35208955-5B976E4F-6778-49EC-8E57-39DA3AC2FF58Q35543478-76C3D2DC-A355-4516-844B-57DDEF614F2CQ35945582-572F9E7E-9F2C-47A7-9667-530CCEAAE130Q36414198-14E3E8DD-EDD8-4EE9-92CD-1DEC2A73C415Q36625470-6F21EBB6-00AF-4B94-862C-795F6BA7EF63Q36641467-85A00658-AF6A-4D5D-8DCD-64734B85C7BDQ36759835-DF8E2C77-4AB3-4696-939E-90B994D50DA3Q36772605-A49E5834-25C6-44A5-9322-A581734F5072Q36931355-EC1560A2-3406-4C2B-B3C3-E52EA4A80757Q37528413-B9B054CA-4243-4411-BA17-2D291CE65A9BQ37728669-92FFB81A-443B-48F2-BA72-D6B367BE1348Q38035144-94FBD407-E942-4D84-912C-DD3B2D359CDFQ38258014-04D365C8-94B9-4F96-9777-D5239A1EDC33Q38261312-A70BF5E2-8026-41C7-86B2-CAF1E3646CA7Q38324695-A037156C-5202-40E2-8E29-BABA4CF9B880Q38347455-2E5EE2C7-B9EA-49C9-A82C-4EC6E0A486A6Q38851888-028B6D37-638A-4D82-8251-3176F6FF9AD1Q38885501-D9CB6999-0CC3-44C8-89C1-628089D87541Q38975570-CC774AB0-FB9A-44DE-A9A1-9180C9F6321DQ39227897-420232DB-98E1-428A-BFF3-7F0F813D1ED9Q39281860-8FD8B878-F631-4AE9-B67B-FB3201653F2CQ42022545-123F5051-2E58-4CD3-AB84-6CB9144D71DCQ42040180-C0CE0DC6-935B-410E-90AB-723EB7020515Q55260487-D3455BCD-C5CA-452D-9A1D-EC91159D7A95Q58788954-DFF393FA-E87E-4571-B050-D616F2886DD6
P2860
A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A combined array-based compara ...... r-30d as an oncomir in cancer.
@ast
A combined array-based compara ...... r-30d as an oncomir in cancer.
@en
type
label
A combined array-based compara ...... r-30d as an oncomir in cancer.
@ast
A combined array-based compara ...... r-30d as an oncomir in cancer.
@en
prefLabel
A combined array-based compara ...... r-30d as an oncomir in cancer.
@ast
A combined array-based compara ...... r-30d as an oncomir in cancer.
@en
P2093
P2860
P1433
P1476
A combined array-based compara ...... r-30d as an oncomir in cancer.
@en
P2093
Arto Leminen
Barbara L Weber
Dionyssios Katsaros
George Coukos
Heini Lassus
Joel Greshock
Qihong Huang
Ralf Bützow
P2860
P304
P356
10.1158/0008-5472.CAN-11-2484
P407
P577
2011-11-04T00:00:00Z